Vir Biotechnology, Inc.
Vir Biotechnology, Inc.（VIR）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
vir · 股价预测 · 12 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 12 位华尔街分析师
Buy
12 位分析师
共识
评级分布
12 个月目标价
High
$30.00
Consensus
$21.14
+151.6% upside
Low
$18.00
Median: $20 · Last Close: $8.40
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$21.14
151.6% upside
High Target
$30
257.0%
Low Target
$18
114.2%
Current Price
$8.40
as of today
Based on analyst price targets, the VIR stock price prediction for the next 12 months ranges from $18 to $30. The consensus VIR price forecast of $21.14 implies 151.6% upside from the current price of $8.40.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.22 | ↓ 2.17% |
1-day model range: $8.17–$8.27. Peak: $8.27 (-2.17%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -45.8% |
| 2028 | $3 | -59.5% |
| 2029 | $3 | -65.1% |
| 2030 | $3 | -67.8% |
| 2031 | — | -69.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · VIR · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-24 | Needham | Maintains | Buy→Buy |
| 2026-02-24 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-02-24 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-02-09 | Needham | Maintains | Buy→Buy |
| 2025-12-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-27 | B of A Securities | Upgrade ↑ | Neutral→Buy |
Wall Street analysts have recently issued updated ratings on Vir Biotechnology, Inc. (VIR) stock. Of the recent 95 rating actions, 9 were upgrades and 8 were downgrades. 12 analysts currently cover VIR.
分析师推荐趋势
VIR analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$162M
↑ 6.0% YoY
Revenue Next Year
$97M
↓ 40.1% YoY
EPS This Year
$-1.93
EPS Next Year
$-2.33
↑ 20.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast VIR EPS of $-1.93 for the current fiscal year, based on estimates from 4 analysts. The VIR revenue forecast is $162M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
VIR 股价预测由两类独立数据源支撑：来自 12 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。VIR 的共识目标价为 $21.14（+151.6% 上行空间），分析师共识为 Buy。
VIR 的短期预测（明日）为 $8.22（-2.17%）。 VIR 对 2027 年的股价预测均值为 $5。 VIR 对 2030 年的预测区间为 $3–$3。
Vir Biotechnology, Inc. 在 NASDAQ 上市，代码 VIR。VIR 在 2027 年的整体展望偏积极，在覆盖分析师中约 83% 对应 Buy 共识。
常见问题
VIR 预测 · 8 个问题根据 12 位华尔街分析师，VIR 的 12 个月平均目标价为 $21.14，最高 $30.00、最低 $18.00。若有图表，中位目标价可在上方查看。相对当前价 $8.40，隐含约 +151.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.